Thyrocare Tech Q2 Results: Profit surges 79% YoY; margins, volumes rise

Higher test volumes and increased efficiency helped Thyrocare Technologies Ltd. post a good July–September quarter, with net profit increasing 79% year over year to ₹48 crore. EBITDA increased 47.5% to ₹71.3 crore, while revenue increased 22% to ₹216.5 crore from ₹177.4 crore the previous year. Operating margins increased from 27.2% to 32.9%. The pathology segment's ongoing growth in both core and associated services was highlighted by the strong 35% increase in partnership revenue and the 20% year-over-year growth in franchise revenue. The diagnostics chain reaffirmed its position as India's leading diagnostic test volume processor by processing 53.3 million tests in Q2 FY26, a 21% year-over-year increase.